JD Health International Inc. disclosed on 8 June 2026 that its issued share capital remains at 3.21 billion ordinary shares, with no treasury shares outstanding.

The company executed an on-market buy-back of 0.30 million shares on 8 June at prices between HK$36.12 and HK$37.10, spending HK$10.94 million. All repurchased shares are earmarked for cancellation.

Including this latest transaction, JD Health has repurchased 16.47 million shares under the general mandate approved on 20 June 2025. The aggregate represents 0.515 % of the company’s issued shares on the mandate date.

Since 15 May 2026, JD Health has carried out 11 repurchase tranches—ranging from 0.20 million to 2.54 million shares per day—at volume-weighted average prices between HK$36.48 and HK$45.17. All 16.47 million shares are pending cancellation.

Following the 8 June activity, the company’s total number of issued shares stands unchanged at 3.21 billion. A 30-day moratorium on new share issues or treasury-share disposals runs through 8 July 2026 under Hong Kong listing regulations.